Safety Rates Drug Report: LORAZEPAM. Posterior reversible encephalopathy syndrome adverse events in 2016 Q3 - FDA prescription drugs adverse events in an open, searchable, online, public database

The Safety Rates Drug Report

2004.Q1 2004.Q2 2004.Q3 2004.Q4 2005.Q1 2005.Q2 2005.Q3 2005.Q4 2006.Q1 2006.Q2 2006.Q3 2006.Q4 2007.Q1 2007.Q2 2007.Q3 2007.Q4 2008.Q1 2008.Q2 2008.Q3 2008.Q4 2009.Q1 2009.Q2 2009.Q3 2009.Q4 2010.Q1 2010.Q2 2010.Q3 2010.Q4 2011.Q1 2011.Q2 2011.Q3 2011.Q4 2012.Q1 2012.Q2 2012.Q3 2012.Q4 2013.Q1 2013.Q2 2013.Q3 2013.Q4 2014.Q1 2014.Q2 2014.Q3 2014.Q4 2015.Q1 2015.Q2 2015.Q3 2015.Q4 2016.Q1 2016.Q2 2016.Q3

Drug Injury Quarter

Drug: LORAZEPAM. Injury: Posterior reversible encephalopathy syndrome Quarter: 2016Q3

|< 1/2 << Previous Page Page 1

Total Records: 9 Number of Pages: 1

Event ID	DRUGNAME	PT	Drug Manufacturer	Patient Age	Sex	Weight	Date (YYYYMMDD)	Country
125412671	LORAZEPAM.	Posterior reversible encephalopathy syndrome	WESTWARD	9.00 YR	M	0	20160708	US
125439062	LORAZEPAM.	Posterior reversible encephalopathy syndrome	ALVOGEN	9.00 YR	M	0	20160919	US
125442702	LORAZEPAM.	Posterior reversible encephalopathy syndrome	UCB	9.00 YR	M	0	20160720	US
125463912	LORAZEPAM.	Posterior reversible encephalopathy syndrome	TEVA	9.00 YR	M	0	20160712	US
125515031	LORAZEPAM.	Posterior reversible encephalopathy syndrome	BAUSCH AND LOMB	9.00 YR	M	0	20160713	US
125523671	LORAZEPAM.	Posterior reversible encephalopathy syndrome	RANBAXY	9.00 YR	M	0	20160713	GB
125552081	LORAZEPAM.	Posterior reversible encephalopathy syndrome	CIPLA	0.00		0	20160714	US
125729391	LORAZEPAM.	Posterior reversible encephalopathy syndrome	ACCORD	9.00 YR	M	0	20160720	US
125731831	LORAZEPAM.	Posterior reversible encephalopathy syndrome	AUROBINDO	9.00 YR	M	0	20160720	US

|< 1/2 << Previous Page Page 1

Total Records: 9 Number of Pages: 1

Execution Time: 0.044672012329102 seconds (ucode:5149236). Developed by: James D. Barger